Covington advised lead investors Abingworth and other syndicate members on the round. Ascend closed its $130 million Series A fundraise. Ascend will use the proceeds to launch...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised NEA and Abingworth on the transaction. Escient Pharmaceuticals announced that it had raised $120 million through a Series C Financing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Travers Smith advised Abingworth on the deal, while Debevoise & Plimpton advised Carlyle. Abingworth announced its proposed acquisition by global investment firm Carlyle (NASDAQ:...
You must be a Standard 1 Year member to access this content.
VISCHER advised Anjarium Biosciences on the deal. Baker McKenzie advises a consortium of life science funds, including Abingworth and Gimv, alongside Omega Funds, Pfizer Ventures and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Abingworth on the deal. Abingworth announced the formation of its latest transatlantic venture fund, Abingworth Bioventures 8 (ABV 8), which closed at...
You must be a Standard 1 Year member to access this content.
